Literature DB >> 24574781

Expression of granulocyte colony-stimulating factor receptor in rectal cancer.

Xiao-Dong Yang1, Ping Huang1, Feng Wang1, Ze-Kuan Xu1.   

Abstract

AIM: To evaluate whether granulocyte colony-stimulating factor receptor (G-CSFR) expression before preoperative irradiation can predict the radiosensitivity of rectal cancer.
METHODS: The expression of G-CSFR was examined, using immunohistochemistry, in biopsy specimens from 126 patients with locally advanced rectal adenocarcinoma before preoperative irradiation. Radiosensitivity was then evaluated according to the Rectal Cancer Regression Grading. Endoscopic inspection was used to detect the tumor area in each patient. General patient information, such as age, gender, lymph node status, tumor size and degree of differentiation was recorded. A statistical analysis was then performed to evaluate the correlation between clinical or pathological parameters and G-CSFR expression in tumors.
RESULTS: According to endoscopic inspection, the tumor area ranged from 4 to 48 cm² (median, 15 cm²). Positive G-CSFR immunoreactions (G-CSFR⁺) were observed in 85 specimens, and negative (G-CSFR⁻) in 41. No significant differences were found in age, gender, tumor invasion, lymph node status and tumor size between G-CSFR⁺ and G-CSFRpatients. G-CSFR expression was positively correlated with poor radiotherapy response (58.8% vs 75.6%, P = 0.014, r = 0.219). The proportion of well-differentiated tumors in G-CSFR⁺ and G-CSFRpatients was 24.7% and 36.6%, respectively. Sphincter preservation was observed in 57.6% of G-CSFRpatients and 78.5% of G-CSFRpatients. Significant correlations were found between G-CSFR expression and tumor differentiation (24.7% vs 36.6%, P = 0.019, r = 0.210), as well as sphincter preservation (57.6% vs 78.5%, P = 0.044, r = 0.180).
CONCLUSION: The expression of G-CSFR before preoperative irradiation may predict the radiosensitivity of rectal cancer.

Entities:  

Keywords:  Predictive factor; Radiosensitivity; Radiotherapy; Rectal cancer; Tumor

Mesh:

Substances:

Year:  2014        PMID: 24574781      PMCID: PMC3921532          DOI: 10.3748/wjg.v20.i4.1074

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth.

Authors:  T Kikuchi; S Nakahara; T Abe
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Cell-level pharmacokinetic model of granulocyte colony-stimulating factor: implications for ligand lifetime and potency in vivo.

Authors:  Casim A Sarkar; Douglas A Lauffenburger
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

3.  The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines.

Authors:  H Quentmeier; M Zaborski; H G Drexler
Journal:  Leuk Res       Date:  1997-04       Impact factor: 3.156

4.  Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007).

Authors:  J J Walker; D H Brewster; H M Colhoun; C M Fischbacher; R S Lindsay; S H Wild
Journal:  Diabetologia       Date:  2013-04-27       Impact factor: 10.122

5.  Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.

Authors:  X Yang; F Liu; Z Xu; C Chen; X Wu; G Li; J Li
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

6.  Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy.

Authors:  Wael A Ahmed; Kenji Suzuki; Yoshihiro Imaeda; Yoshimune Horibe
Journal:  Auris Nasus Larynx       Date:  2007-11-08       Impact factor: 1.863

7.  A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.

Authors:  V Penopoulos; M Handolias; A Avgerinos; T Maris; T Ilias; N Issopoulos; G Christianopoulos; D Betsis; E Vrettou; G Kitis; K Pistevou
Journal:  Hepatogastroenterology       Date:  2008 Jul-Aug

8.  Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.

Authors:  In Ja Park; Hee Cheol Kim; Chang Sik Yu; Tae Won Kim; Se Jin Jang; Jin Cheon Kim
Journal:  Ann Surg Oncol       Date:  2007-10-25       Impact factor: 5.344

9.  Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.

Authors:  Sang Min Yoon; Dae Yong Kim; Tae Hyun Kim; Kyung Hae Jung; Hee Jin Chang; Woong Sub Koom; Seok-Byung Lim; Hyo Seong Choi; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

Review 10.  Surgical therapy for colorectal adenocarcinoma.

Authors:  Neal Wilkinson; Carol E H Scott-Conner
Journal:  Gastroenterol Clin North Am       Date:  2008-03       Impact factor: 3.806

View more
  3 in total

Review 1.  The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Authors:  Belinda Yeo; Andrew D Redfern; Kellie A Mouchemore; John A Hamilton; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2018-07-02       Impact factor: 5.150

Review 2.  Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.

Authors:  Carol Ward; James Meehan; Mark Gray; Ian H Kunkler; Simon P Langdon; David J Argyle
Journal:  Metabolites       Date:  2018-02-10

3.  Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact.

Authors:  Zhen Su; Yan-Ping Mao; Pu-Yun OuYang; Jie Tang; Fang-Yun Xie
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.